Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT: Progestagens for Preterm Delivery
NCT01178788Phase 3Completed
- Sponsor
- University of Modena and Reggio Emilia
- Start
- Feb 2010
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hydroxyprogesterone caproate and progesterone in preterm birth (3 arms), sponsored by University of Modena and Reggio Emilia. Primary endpoint: Preterm delivery (37 weeks of gestation). Started Feb 2010; status: completed.
02
Drugs
hydroxyprogesterone caproateprogesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT01178788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178788.